Digital therapeutics (DTx) were gaining popularity as tools to help slash the US’ $3 trillion annual spending on chronic disease, and the pandemic has vaulted digital therapies into the spotlight. Now, the Teladoc-Livongo megamerger is heating up competition in the DTx space as players race to capture a slice of a market slated to reach $56 billion by 2025.

Another addressable Sling campaign produced a 21% sales lift for an OTC product during a 90-day window. Media agency attendees echoed the sell-side experience in results for some of their advertiser clients. Addressable TV has been buoyed by two key evolutionary developments.